Drug Patent Expirations for Aug 11, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

KAZANO (alogliptin benzoate; metformin hydrochloride)
Takeda Pharms Usa
Patent number: 6,303,640
Expiration Date: Aug 9, 2016

DUETACT (glimepiride; pioglitazone hydrochloride)
Takeda Pharms Usa
Patent number: 6,303,640
Expiration Date: Aug 9, 2016

OSENI (alogliptin benzoate; pioglitazone hydrochloride)
Takeda Pharms Usa
Patent number: 6,303,640
Expiration Date: Aug 9, 2016

NESINA (alogliptin benzoate)
Takeda Pharms Usa
Patent number: 6,303,640
Expiration Date: Aug 9, 2016

ACTOS (pioglitazone hydrochloride)
Takeda Pharms Usa
Patent number: 6,303,640
Expiration Date: Aug 9, 2016

POMALYST (pomalidomide)
Celgene
Patent number: 6,316,471
Expiration Date: Aug 10, 2016

POMALYST (pomalidomide)
Celgene
Patent number: 8,158,653
Expiration Date: Aug 10, 2016

ABRAXANE (paclitaxel)
Abraxis Bioscience
Patent number: RE 41,884
Expiration Date: Aug 14, 2016

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial

Click here for reuse options!
Copyright 2016 Biotechblog

Leave a Reply

%d bloggers like this: